Used primarily in pharmaceutical research, Sodium 2-(isoquinolin-1-yl)acetate serves as a key intermediate in the synthesis of various bioactive compounds. Its structure is particularly valuable in developing drugs targeting neurological disorders, as the isoquinoline moiety is known for its affinity to certain receptors in the brain. Additionally, it is employed in the study of enzyme inhibition, aiding in the discovery of potential treatments for diseases like cancer and inflammation. Its water-soluble nature makes it suitable for use in aqueous-based formulations and biochemical assays.